TBXT and neoplasm: Simultaneously, T-cell receptor signalling can upregulate the expression of PD-1 on T cells, and the interaction between PD-1 and PD-L1 can lead to misidentification of tumour cells by T cells, thus playing a negative role in the anti-tumour effect [45, 46].